$SWKH
SWK Holdings Corp Stock $swkh

$swkh Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000155278124000162 Filed on March 20, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$11.78M	$9.890M	$37.76M
YoY Change	25.16%	0.95%	-8.98%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$8.007M	$5.087M	$13.14M
YoY Change	215.24%	-14.19%	-20.12%
% of Gross Profit
Research & Development	$530.0K	$602.0K	$3.436M
YoY Change	-26.29%	-66.16%	-50.58%
% of Gross Profit
Depreciation & Amortization	$514.0K	$637.0K	$2.577M
YoY Change	-20.68%	0.31%	-0.85%
% of Gross Profit
Operating Expenses	$530.0K	$6.329M	$3.436M
YoY Change	-26.29%	-24.13%	-50.58%
Operating Profit
YoY Change
Interest Expense	$1.256M	$5.454M	$1.849M
YoY Change	590.11%	-193.49%	443.82%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$1.090M	$611.0K	$14.61M
YoY Change	-75.92%	-113.95%	53.97%
Income Tax	$229.0K	-$2.233M	-$1.274M
% Of Pretax Income	21.01%	-365.47%	-8.72%
Net Earnings	$861.0K	$2.844M	$15.89M
YoY Change	-81.42%	0.42%	17.76%
Net Earnings / Revenue	7.31%	28.76%	42.07%
Basic Earnings Per Share	$0.07		$1.26
Diluted Earnings Per Share	$0.07	$0.23	$1.25
COMMON SHARES
Basic Shares Outstanding	12.50M shares	12.50M shares	12.65M shares
Diluted Shares Outstanding	12.54M shares		12.70M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.498M	$4.503M	$4.503M
YoY Change	69.48%	-26.85%	-26.85%
Cash & Equivalents	$5.498M	$4.503M	$4.503M
Short-Term Investments
Other Short-Term Assets	$2.086M	$1.904M	$2.637M
YoY Change	62.08%	70.92%	136.71%
Inventory
Prepaid Expenses
Receivables	$6.352M	$4.729M	$4.729M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$13.94M	$11.87M	$11.87M
YoY Change	57.01%	14.52%	14.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.212M	$5.438M	$5.438M
YoY Change	-7.38%	-6.88%	-6.88%
Goodwill
YoY Change
Intangibles	$6.198M	$6.487M
YoY Change	-20.17%	-20.79%
Long-Term Investments	$394.0K	$48.00K	$48.00K
YoY Change	496.97%	-36.84%	-36.84%
Other Assets	$3.888M	$3.109M	$35.91M
YoY Change	61.93%	78.47%	18.93%
Total Long-Term Assets	$308.4M	$322.4M	$322.4M
YoY Change	5.67%	11.45%	11.45%
TOTAL ASSETS
Total Short-Term Assets	$13.94M	$11.87M	$11.87M
Total Long-Term Assets	$308.4M	$322.4M	$322.4M
Total Assets	$322.4M	$334.3M	$334.3M
YoY Change	7.19%	11.56%	11.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.867M	$3.935M	$3.935M
YoY Change	59.28%	0.85%	0.85%
Accrued Expenses
YoY Change
Deferred Revenue		$9.000K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.376M	$3.944M	$3.944M
YoY Change	-64.47%	-37.86%	-37.86%
LONG-TERM LIABILITIES
Long-Term Debt	$30.93M	$43.13M	$43.13M
YoY Change
Other Long-Term Liabilities	$1.859M	$1.964M	$6.864M
YoY Change	-34.47%	-8.44%	-48.57%
Total Long-Term Liabilities	$1.859M	$1.964M	$50.00M
YoY Change	-34.47%	-8.44%	274.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.376M	$3.944M	$3.944M
Total Long-Term Liabilities	$1.859M	$1.964M	$50.00M
Total Liabilities	$42.06M	$53.94M	$53.94M
YoY Change	59.62%	173.91%	173.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.144B	-$4.145B
YoY Change	-0.29%	-0.15%
Common Stock	$12.00K	$12.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$280.3M	$280.3M	$280.3M
YoY Change
Total Liabilities & Shareholders Equity	$322.4M	$334.3M	$334.3M
YoY Change	7.19%	11.56%	11.56%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$861.0K	$2.844M	$15.89M
YoY Change	-81.42%	0.42%	17.76%
Depreciation, Depletion And Amortization	$514.0K	$637.0K	$2.577M
YoY Change	-20.68%	0.31%	-0.85%
Cash From Operating Activities	$4.430M	$5.697M	$14.89M
YoY Change	567.17%	84.07%	81.5%
INVESTING ACTIVITIES
Capital Expenditures		$196.0K	$496.0K
YoY Change		90.29%	67.0%
Acquisitions
YoY Change
Other Investing Activities	$9.181M	-$52.32M	-$48.45M
YoY Change	-182.91%	234.52%	12.03%
Cash From Investing Activities	$9.181M	-$52.52M	-$48.95M
YoY Change	-182.85%	233.57%	12.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$6.327M
YoY Change			455.98%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$13.35M	21.02M	$33.14M
YoY Change	-277.84%	-3638.72%	-2534.97%
NET CHANGE
Cash From Operating Activities	$4.430M	5.697M	$14.89M
Cash From Investing Activities	$9.181M	-52.52M	-$48.95M
Cash From Financing Activities	-$13.35M	21.02M	$33.14M
Net Change In Cash	$262.0K	-25.80M	-$920.0K
YoY Change	-109.0%	94.83%	-97.49%
FREE CASH FLOW
Cash From Operating Activities	$4.430M	$5.697M	$14.89M
Capital Expenditures		$196.0K	$496.0K
Free Cash Flow	$4.430M	$5.501M	$14.39M
YoY Change	575.3%	83.86%	82.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q4	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2022Q4	us-gaap	Unsecured Debt UnsecuredDebt		usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2023	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss		usd
CY2023	swkh	Increase Decrease In Collateral On Forward Currency Exchange Contract IncreaseDecreaseInCollateralOnForwardCurrencyExchangeContract		usd
CY2023	swkh	Net Settlement For Employee Taxes On Restricted Stock And Options NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions		usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2022	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable		usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities		usd
CY2023	swkh	Fair Value Of Common Stock Received Upon Exercise Of Warrant FairValueOfCommonStockReceivedUponExerciseOfWarrant		usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs		usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery		usd
CY2022	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses		usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax		usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax		usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax		usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax		usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt		usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet		usd
CY2022Q4	us-gaap	Unsecured Debt UnsecuredDebt		usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths		usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths		usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo		usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo		usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree		usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree		usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour		usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt		usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M11D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y7M6D
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y10M24D
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses		usd
CY2022Q4	swkh	Deferred Tax Assets Asc326 Adoption DeferredTaxAssetsASC326Adoption		usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	58133885	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12497109	shares
CY2023	dei	Auditor Firm AuditorFirmId	207
CY2023	dei	Auditor Name AuditorName	BPM LLP
CY2023	dei	Auditor Location AuditorLocation	San Francisco, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4503000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6156000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	733000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	4729000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	3094000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1904000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1114000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	11869000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	10364000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	274504000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	236555000	usd
CY2023Q4	us-gaap	Derivative Instruments And Hedges DerivativeInstrumentsAndHedges	2750000	usd
CY2022Q4	us-gaap	Derivative Instruments And Hedges DerivativeInstrumentsAndHedges	2750000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	48000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	76000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	28290000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	24480000	usd
CY2023Q4	swkh	Warrant Assets WarrantAssets	1759000	usd
CY2022Q4	swkh	Warrant Assets WarrantAssets	1220000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8404000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6487000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8190000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5438000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5840000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3109000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1742000	usd
CY2023Q4	us-gaap	Assets Assets	334254000	usd
CY2022Q4	us-gaap	Assets Assets	299621000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3944000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3902000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2445000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3944000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6347000	usd
CY2023Q4	swkh	Contingent Consideration Payable ContingentConsiderationPayable	4900000	usd
CY2022Q4	swkh	Contingent Consideration Payable ContingentConsiderationPayable	11200000	usd
CY2023Q4	us-gaap	Unsecured Debt UnsecuredDebt	30781000	usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	12350000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1964000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2145000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	53939000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	19692000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12497770	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12843157	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4425104000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4430922000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4144801000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4151005000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	280315000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	279929000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	334254000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	299621000	usd
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	35461000	usd
CY2023	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	212000	usd
CY2023	us-gaap	Revenues Revenues	37760000	usd
CY2022	us-gaap	Revenues Revenues	41484000	usd
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	1912000	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	3491000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8404000	usd
CY2023	us-gaap	Interest Expense InterestExpense	1849000	usd
CY2022	us-gaap	Interest Expense InterestExpense	340000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3436000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6952000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11232000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12964000	usd
CY2023	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	-6300000	usd
CY2022	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	5170000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2577000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2599000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	-14650000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	-9968000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-55000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	417000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-528000	usd
CY2023	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-799000	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-151000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	817000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	-215000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	14613000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9491000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1274000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	15887000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	13491000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.25
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12653000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12835000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12696000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12880000	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	267236000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	500000	usd
CY2022	swkh	Net Settlement For Employee Taxes On Restricted Stock And Options NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions	-160000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1138000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	13491000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	279929000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	509000	usd
CY2023	swkh	Effect Of Adoption Of Accounting Standard EffectOfAdoptionOfAccountingStandard	-9683000	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6327000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	15887000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	280315000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	15887000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	13491000	usd
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	1912000	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	3491000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	493000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	69000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8404000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	333000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	229000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1286000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-3941000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	55000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-417000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-528000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	799000	usd
CY2023	swkh	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-1876000	usd
CY2022	swkh	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	754000	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-151000	usd
CY2023	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	-6300000	usd
CY2022	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	5170000	usd
CY2023	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	3827000	usd
CY2022	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	2204000	usd
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	1826000	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	5995000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	509000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	500000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2577000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2599000	usd
CY2023	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-1635000	usd
CY2022	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-1291000	usd
CY2023	swkh	Derivative Instrument Receivable DerivativeInstrumentReceivable	1059000	usd
CY2022	swkh	Derivative Instrument Receivable DerivativeInstrumentReceivable	-539000	usd
CY2022	swkh	Increase Decrease In Collateral On Forward Currency Exchange Contract IncreaseDecreaseInCollateralOnForwardCurrencyExchangeContract	-2750000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	787000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	44000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	396000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1599000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14887000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8202000	usd
CY2023	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	13942000	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	4151000	usd
CY2023	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	74125000	usd
CY2022	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	93118000	usd
CY2023	swkh	Proceeds Repayment Of Finance Receivables ProceedsRepaymentOfFinanceReceivables	11703000	usd
CY2022	swkh	Proceeds Repayment Of Finance Receivables ProceedsRepaymentOfFinanceReceivables	45673000	usd
CY2023	swkh	Marketable Investment Principal Payment MarketableInvestmentPrincipalPayment	28000	usd
CY2022	swkh	Marketable Investment Principal Payment MarketableInvestmentPrincipalPayment	43000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	496000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	297000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-48948000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43548000	usd
CY2022	swkh	Net Settlement For Employee Taxes On Restricted Stock And Options NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions	-160000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3407000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6327000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1138000	usd
CY2023	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	32969000	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	9905000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	2437000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33140000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1361000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-920000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-36707000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6156000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42863000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5236000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6156000	usd
CY2023	swkh	Warrants Received In Conjunction With Purchase Of Financial Receivables WarrantsReceivedInConjunctionWithPurchaseOfFinancialReceivables	1364000	usd
CY2022	swkh	Warrants Received In Conjunction With Purchase Of Financial Receivables WarrantsReceivedInConjunctionWithPurchaseOfFinancialReceivables	1180000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1351000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	268000	usd
CY2022	swkh	Fair Value Of Common Stock Received Upon Exercise Of Warrant FairValueOfCommonStockReceivedUponExerciseOfWarrant	3667000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zODUC67Zbfe8" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><span style="font-size: 10pt"><b><i><span id="xdx_86E_zLK7pgszT8Ac">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><span style="font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are required in the determination of revenue recognition; stock-based compensation; valuation of accounts receivable; impairment of finance receivables; long-lived assets; property and equipment; intangible assets; goodwill; valuation of warrants and other investments; contingent consideration; income taxes; and contingencies and litigation, among others. Some of these judgments can be subjective and complex, and consequently, actual results may differ from these estimates. The Company’s estimates often are based on complex judgments, probabilities and assumptions that it believes to be reasonable but that are inherently uncertain and unpredictable. For any given individual estimate or assumption made by the Company, there may also be other estimates or assumptions that are reasonable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">The Company regularly evaluates its estimates and assumptions using historical experience and other factors, including the economic environment. As future events and their effects cannot be determined with precision, the Company’s estimates and assumptions may prove to be incomplete or inaccurate, or unanticipated events and circumstances may occur that might cause changes to those estimates and assumptions. Market conditions, such as illiquid credit markets, health crises such as the COVID-19 global pandemic, volatile equity markets, and economic downturns, can increase the uncertainty already inherent in the Company’s estimates and assumptions. The Company adjusts its estimates and assumptions when facts and circumstances indicate the need for change. Those changes generally will be reflected in our consolidated financial statements on a prospective basis unless they are required to be treated retrospectively under the relevant accounting standard. It is possible that other professionals, applying reasonable judgment to the same facts and circumstances, could develop and support a range of alternative estimated amounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><span style="font-size: 10pt"> </span></p>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	number
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	600000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	600000	usd
CY2023	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p id="xdx_841_eus-gaap--RevenueRecognitionDeferredRevenue_z0ZRdiRLk6T4" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-size: 10pt"><b><i><span id="xdx_864_z3q1PcYZyD9i">Deferred Revenue and Deferred Costs</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">Deferred revenue includes amounts that have been billed per the contractual terms but have not been recognized as revenue. The Company classifies as current the portion of deferred revenue that is expected to be recognized within one year from the balance sheet date. Deferred revenue was $<span id="xdx_903_eus-gaap--DeferredRevenue_iI_pp0d_c20231231_zi20Z1RIRE8a">9,000</span> and $<span id="xdx_905_eus-gaap--DeferredRevenue_iI_pp0d_c20221231_zkmYv0WX5Yl3">33,000</span> as of December 31, 2023 and 2022, respectively, and is included in accounts payable and accrued liabilities in the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	9000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	33000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<p id="xdx_840_eus-gaap--FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_zfYrwF2LNJJf" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="font-size: 10pt"><b><i><span id="xdx_860_zRnBhEvIT41h">Allowance for Credit Losses on Finance Receivables</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">The allowance for credit losses is intended to provide for credit losses inherent in the finance receivables portfolio and is periodically reviewed for adequacy considering credit quality indicators, including expected and historical losses and levels of and trends in past due loans, non-performing assets and impaired loans, collateral values and economic conditions. The allowance for credit losses is determined based on specific allowances for loans that are impaired, based upon the value of underlying collateral or projected cash flows. Changes to the allowance for credit losses are recorded in the provision for loan credit losses in the consolidated statements of income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">The Company adopted Accounting Standards Update 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), as amended, on January 1, 2023 using the modified retrospective approach method. See Recent Accounting Pronouncements section below and Note 3 for further information. </span></p>
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1700000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_ziHThdNUkSh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="font-size: 10pt"><b><i><span id="xdx_86B_ziFYpXTQIN95">Certain Risks and Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, interest and accounts receivable, finance receivables and marketable investments. The Company invests its excess cash with major U.S. banks and financial institutions. The Company has not experienced any losses on its cash and cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><span style="font-size: 10pt"><i>Finance Receivables Segment</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">The Company performs ongoing credit evaluations of its partner companies and generally requires collateral. For the year ended December 31, 2023, three of our business partners accounted for 35 percent of our interest and accounts receivable. For the year ended December 31, 2022, two of our business partners accounted for 31 percent of our interest and accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><span style="font-size: 10pt"><i>Pharmaceutical Development Segment</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">For the years ended December 31, 2023 and 2022, Cara accounted for approximately 23 percent and 87 percent, respectively, of Pharmaceutical Development segment revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">The Company does not expect its current or future credit risk exposures to have a significant impact on its operations. However, there can be no assurance that its business will not experience any adverse impact from credit risk in the future.</span></p>
CY2023	us-gaap	Profit Loss ProfitLoss	15887000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	13491000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12653000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12835000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	45000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12696000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12880000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.25
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	122000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	248000	shares
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	29850000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	23363000	usd
CY2023Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	6487000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	29850000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21660000	usd
CY2022Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	8190000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1546000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1076000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1076000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1076000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1036000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	677000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6487000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	288405000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	248401000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13901000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11846000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	274504000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	236555000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11846000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8388000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	11846000	usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	33000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	11786000	usd
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	2115000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13901000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	288405000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	248401000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13901000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11846000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	274504000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	236555000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	77925000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	63420000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1233000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	472000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	49416000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	28295000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	37503000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	31846000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	288405000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	4079000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	3895000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	198000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	59000	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3645000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3656000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	192000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	87000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8114000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7697000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2676000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1857000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5438000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5840000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	48000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	76000	usd
CY2023Q4	us-gaap	Investments Investments	48000	usd
CY2022Q4	us-gaap	Investments Investments	76000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	336000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	49000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	2000	usd
CY2023	us-gaap	Lease Cost LeaseCost	521000	usd
CY2022	us-gaap	Lease Cost LeaseCost	338000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	48000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	48000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	76000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	76000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	12400000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	2400000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	32969000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2188000	usd
CY2023Q4	us-gaap	Unsecured Debt UnsecuredDebt	30781000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	32969000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	32969000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2085000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1692000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	367000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	235000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1863000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1509000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2230000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1744000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.063	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.059	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	510000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	504000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	460000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	465000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	272000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2616000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000.0	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	326088	shares
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	67500000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.70
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	63750000	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	12.49
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	9000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	33000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	9000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	33000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	number
CY2023	swkh	Revenues Excluding Other Revenue RevenuesExcludingOtherRevenue	37548000	usd
CY2023	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	212000	usd
CY2023	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1912000	usd
CY2023	us-gaap	Interest Expense InterestExpense	1849000	usd
CY2023	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	-6300000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8404000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3436000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2577000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11232000	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-37000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1274000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	15887000	usd
CY2022	swkh	Revenues Excluding Other Revenue RevenuesExcludingOtherRevenue	40946000	usd
CY2022	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	538000	usd
CY2022	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3491000	usd
CY2022	us-gaap	Interest Expense InterestExpense	340000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6952000	usd
CY2022	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	5170000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2599000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12964000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-477000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	13491000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	14613000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9491000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	13000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-59000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3922000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-54000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-19000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1274000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3070000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2035000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-6697000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-9587000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-52000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-97000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	1765000	usd
CY2023	swkh	Effective Income Tax Rate Reconciliation Mark To Market Adjustments EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments	-50000	usd
CY2022	swkh	Effective Income Tax Rate Reconciliation Mark To Market Adjustments EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments	-88000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	167000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	403000	usd
CY2023	swkh	Effective Income Tax Rate Reconciliation Contingent Consideration Revaluation EffectiveIncomeTaxRateReconciliationContingentConsiderationRevaluation	-1323000	usd
CY2022	swkh	Effective Income Tax Rate Reconciliation Contingent Consideration Revaluation EffectiveIncomeTaxRateReconciliationContingentConsiderationRevaluation	1044000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	116000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	191000	usd
CY2023	swkh	Effective Income Tax Rate Reconciliation Write Off Of Deferred Tax Assets EffectiveIncomeTaxRateReconciliationWriteOffOfDeferredTaxAssets	2064000	usd
CY2022	swkh	Effective Income Tax Rate Reconciliation Write Off Of Deferred Tax Assets EffectiveIncomeTaxRateReconciliationWriteOffOfDeferredTaxAssets	2905000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1274000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2973000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2947000	usd
CY2023Q4	swkh	Deferred Tax Assets Asc326 Adoption DeferredTaxAssetsASC326Adoption	2967000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	153000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	143000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2438000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3846000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19891000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26158000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	28422000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	33094000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	-586000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1288000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-718000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-629000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6697000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	28290000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	24480000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	usd

Files In Submission

Name	View Source	Status
0001552781-24-000162-index-headers.html	Edgar Link	pending
0001552781-24-000162-index.html	Edgar Link	pending
0001552781-24-000162.txt	Edgar Link	pending
0001552781-24-000162-xbrl.zip	Edgar Link	pending
e24067001.jpg	Edgar Link	pending
e24067_ex10-21.htm	Edgar Link	pending
e24067_ex21-1.htm	Edgar Link	pending
e24067_ex23-1.htm	Edgar Link	pending
e24067_ex31-1.htm	Edgar Link	pending
e24067_ex32-1.htm	Edgar Link	pending
e24067_ex97-01.htm	Edgar Link	pending
e24067_swkh-10k.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
e24067_swkh-10k_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
swkh-20231231.xsd	Edgar Link	pending
swkh-20231231_def.xml	Edgar Link	unprocessable
swkh-20231231_lab.xml	Edgar Link	unprocessable
swkh-20231231_pre.xml	Edgar Link	unprocessable
swkh-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SWKH
SWK Holdings Corp Stock $swkh

2024 Q1 Form 10-K Financial Statement

#000155278124000162 Filed on March 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWKH SWK Holdings Corp Stock $swkh

2024 Q1 Form 10-K Financial Statement

#000155278124000162 Filed on March 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWKH
SWK Holdings Corp Stock $swkh